Table 2.
Morbidity data
| All HF Admissions | HFrEF | HFpEF | VHF | |||||
| 2012/2013 | 2015/2016 | 2012/2013 | 2015/2016 | 2012/2013 | 2015/2016 | 2012/2013 | 2015/2016 | |
| Pre-IHFS | Post-IHFS | Pre-IHFS | Post-IHFS | Pre-IHFS | Post-IHFS | Pre-IHFS | Post-IHFS | |
| Coded diagnosis of HF | 420 | 576 | ||||||
| Readmissions<30 days | 35 | 36 | ||||||
| Confirmed HF admissions | 385 | 540 | ||||||
| Subtyped admissions | 350 | 505 | 135 | 210 | 147 | 181 | 68 | 114 |
| Age | 81 | 80 | 78 | 77 | 82 | 81 | 83 | 83 |
| Gender F:M | 169:216 | 265:275 | 49:85 | 66:144 | 67:80 | 110:71 | 37:31 | 69:45 |
| NYHA 1 | 31 (8.1%) | 12 (2.2%) | 7 (5%) | 5 (2%) | 13 (9%) | 3 (2%) | 7 (1%) | 3 (3%) |
| NYHA 2 | 20 (5.2%) | 45 (8.3%) | 10 (7%) | 17 (8%) | 6 (4%) | 11 (6%) | 4 (6%) | 11 (10%) |
| NYHA 3 | 54 (14.0%) | 209 (38.7)% | 15 (11%) | 95 (45%) | 21 (14%) | 63 (35%) | 13 (19%) | 44 (39%) |
| NYHA 4 | 233 (60.5%) | 274 (50.7%) | 86 (64%) | 93 (44%) | 89 (61%) | 104 (57%) | 35 (51%) | 56 (49%) |
| Unknown | 47 (12.2%) | 0 | 17 (13%) | 0 | 18 (12%) | 0 | 9 (13%) | 0 |
| HTN | 140 (36.4%) | 278 (51.5%) | 47 (35%) | 97 (46%) | 48 (33%) | 106 (56%) | 35 (51%) | 56 (49%) |
| Diabetes | 96 (24.9%) | 148 (27.4%) | 41 (30%) | 70 (33%) | 39 (27%) | 56 (31%) | 10 (15%) | 14 (13%) |
| COPD | 58 (15%) | 92 (17%) | 23 (17%) | 36 (17%) | 21 (14%) | 34 (19%) | 9 (13%) | 19 (17%) |
| Mean serum creatinine (mmol/L) | 123 | 129 | 134 | 145 | 119 | 116 | 116 | 123 |
| HTN unknown | 3 | 0 | 0 | 0 | 3 | 0 | 0 | 0 |
| Diabetes unknown | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| COPD unknown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Admissions to cardiology | 121 | 231 | 56 | 114 | 41 | 58 | 20 | 58 |
| Age | 76 | 78 | 74 | 74 | 79 | 78 | 74 | 83 |
| Gender F:M | 46:75 | 103:128 | 21:35 | 31:83 | 17:24 | 36:22 | 8:12 | 36:22 |
| NYHA 1 | 13 (11%) | 3 (1%) | 4 (7%) | 1 (1%) | 5 (12%) | 1 (2%) | 3 (15%) | 1 (2%) |
| NYHA 2 | 5 (4%) | 18 (8%) | 4 (7%) | 8 (7%) | 0 | 3 (5%) | 1 (5%) | 7 (12%) |
| NYHA 3 | 17 (14%) | 107 (46%) | 9 (16%) | 56 (49%) | 5 (12%) | 26 (45%) | 3 (15%) | 25 (43%) |
| NYHA 4 | 77 (64%) | 103 (45%) | 36 (64%) | 49 (43%) | 28 (68%) | 28 (48%) | 10 (50%) | 25 (43%) |
| Unknown | 9 (7%) | 0 | 3 (5%) | 0 | 3 (7%) | 0 | 3 (15%) | 0 |
| HTN | 38 (31%) | 113 (49%) | 20 (36%) | 53 (46%) | 8 (20%) | 31 (53%) | 9 (45%) | 28 (48%) |
| Diabetes | 30 (25%) | 63 (27%) | 16 (29%) | 40 (35%) | 10 (24%) | 15 (26%) | 2 (10%) | 8 (14%) |
| COPD | 11 (9%) | 35 (15%) | 6 (11%) | 16 (14%) | 3 (7%) | 10 (17%) | 2 (10%) | 9 (16%) |
| Mean serum creatinine (mmol/L) | 133 | 142 | 149 | 155 | 117 | 127 | 121 | 132 |
| HTN unknown | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| Diabetes unknown | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| COPD unknown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
COPD, chronic obstructive pulmonary disease; HF, heart failure; HTN, hypertension; IHFS, integrated heart failure service.